Dyne Therapeutics Inc (DYN)

Cost of Revenue

$521.00K

TTM · Period ending: · USD

DYN logo

DYN Cost of Revenue

Latest reported$521.00K
DYN TTM Cost of Revenue ($1.85B → $521.00K)
High-resolution chart · PNG

DYN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Dyne Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
521,000
521,000
521,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
707,000,000
1,494,000,000
2,175,000,000
2,932,000,000
2,808,000,000
2,681,000,000
2,493,000,000
2,281,000,000
2,232,000,000
2,193,000,000
2,196,000,000
2,028,000,000
2,639,000,000
2,405,000,000
2,274,000,000
2,449,000,000
1,622,000,000
1,525,000,000
1,413,000,000
1,145,000,000
1,524,000,000
1,799,000,000
1,592,000,000
1,394,000,000
859,000,000
592,000,000
771,000,000
963,000,000
1,982,000,000
2,018,000,000
1,814,846,677
1,844,846,677
930,846,677
857,846,677
1,361,000,000
1,194,000,000
1,315,000,000
1,612,000,000
1,314,000,000
1,853,000,000
2,000,000,000
2,091,000,000
2,307,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.